CPC A61K 35/39 (2013.01) [A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 9/146 (2013.01); A61K 35/28 (2013.01); A61K 47/36 (2013.01); A61K 2035/128 (2013.01)] | 13 Claims |
1. An implantable therapeutic delivery system comprising:
a nanofibrous core substrate comprising one or more internal spaces wherein one or more therapeutic agents is positioned in the one or more internal spaces; and
an outer biocompatible polymeric coating surrounding said nanofibrous core substrate,
wherein the nanofibrous core substrate contains divalent cations.
|